RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Oklahoma City, OK · +111 more sites
Colorectal Cancer clinical trials in Oklahoma City, OK
17 recruiting colorectal cancer studies with a site in Oklahoma City, OK.
All trials in Oklahoma City, OK · All Colorectal Cancer trials
RecruitingPhase 2NCT05673148
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Sponsor: Alliance for Clinical Trials in Oncology
Oklahoma City, OK · +187 more sites
RecruitingNot applicableNCT07283939
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Sponsor: Alliance for Clinical Trials in Oncology
Oklahoma City, OK · +359 more sites
RecruitingPhase 1NCT06004245
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Sponsor: Vividion Therapeutics, Inc.
Oklahoma City, OK · +15 more sites
RecruitingPhase 1 / Phase 2NCT06445062
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Sponsor: Revolution Medicines, Inc.
Oklahoma City, OK · +31 more sites
RecruitingPhase 1 / Phase 2NCT06751329
A Study of DM002 in Patients With Advanced Solid Tumors
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Oklahoma City, OK · +3 more sites
RecruitingPhase 1NCT05433142
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Sponsor: Xencor, Inc.
Oklahoma City, OK · +19 more sites
RecruitingPhase 1 / Phase 2NCT05691491
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Sponsor: National Cancer Institute (NCI)
Oklahoma City, OK · +22 more sites
RecruitingPhase 1 / Phase 2NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Sponsor: Artios Pharma Ltd
Oklahoma City, OK · +40 more sites
RecruitingPhase 1 / Phase 2NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Sponsor: Merus B.V.
Oklahoma City, OK · +30 more sites
RecruitingPhase 2NCT06937177
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Sponsor: Endevica Bio
Oklahoma City, OK · +24 more sites
RecruitingPhase not listedNCT07327489
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Sponsor: Elephas
Oklahoma City, OK · +7 more sites
RecruitingPhase 1NCT06720987
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Sponsor: Kumquat Biosciences Inc.
Oklahoma City, OK · +10 more sites
RecruitingPhase 1NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
Sponsor: Nurix Therapeutics, Inc.
Oklahoma City, OK · +9 more sites
RecruitingPhase not listedNCT05234177
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Sponsor: Tempus AI
Oklahoma City, OK · +19 more sites
Not yet recruitingPhase not listedNCT07732686
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Sponsor: University of Oklahoma
Oklahoma City, OK
Not yet recruitingNot applicableNCT07115875
Improving Rates of Diagnostic Colonoscopy in Native Americans
Sponsor: University of Oklahoma
Oklahoma City, OK
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.